Article · 19 Feb 2026
Research articlePublished 10 Jun 2022
Use of Convalescent Plasma Therapy with Best Available Treatment (BAT) among Hospitalized COVID-19 Patients: A Multi-Center Study
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Introduction: The Novel Coronavirus (COVID-19) has gripped our country with strain as well as effecting our health system. Currently, there are no standard guidelines in its treatment but the possible benefits of convalescent plasma in limiting complications and treating COVID-19 disease is being looked upon. Objective: This study aims to determine the effectiveness and safety of using convalescent plasma in improving clinical course of hospitalized patients diagnosed with COVID-19. Methods: This is a quasi-experimental (prospective analytical) multi-center study of 65 patients who received convalescent plasma therapy (CPT). Results: Median age of patients who were given CPT was 60 years, were predominantly male (68%), and presented with severe COVID-19 pneumonia. Median hemoglobin presented was 138 g/dl, median WBC count was 7.54 × 10 9 /L and median platelet count was 239,500 × 109/L. All inflammatory markers were increased, and both PaO2 and PFR were deranged. Statistically significant decrease in hemoglobin and LDH, and increase in platelet were seen after intervention of CPT. There was statistically significant longer length of stay among CPT recipients, and there was also noted less mortality in BAT group although this is insignificant. Conclusion: Convalescent plasma may have shown no significant impact in the recovery rate and outcome compared to patients who have not received convalescent plasma therapy, but its administration was proven to be safe among all patients regardless of the level of severity and clinical profile.
Subjects
HaematologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Blood & Lymph.
Commentary · 1 Jan 2026
Commentary on Prosthetic Valve Dysfunction Post-Bevacizumab: A TAVR Thrombosis
Commentary · 1 Jan 2026
The Interaction of Blood and Lymphatic Systems: Insights for Modern Hemato-Lymphatic Research
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Blood & Lymph
- SubjectHaematology
- BylineArticles whose byline prints “Flordeluna Z Mesina”
- BylineArticles whose byline prints “Jomell C Julian”
- BylineArticles whose byline prints “Jesus Relos”
- BylineArticles whose byline prints “Rosalio Torres”
- BylineArticles whose byline prints “Maureen Via M Comia”
- BylineArticles whose byline prints “June Marie P Ongkingco”
- BylineArticles whose byline prints “Jimmy R. Lafavilla”
